Fortrea Holdings/$FTRE
1D1W1MYTD1Y5YMAX
About Fortrea Holdings
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
- Ticker
- $FTRE
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 14,000
- Headquarters
- Durham, United States
- Website
- www.fortrea.com
Fortrea Holdings Metrics
BasicAdvanced
$1.7B
-
-$0.92
2.01
-
Price and volume
Market cap
$1.7B
Beta
2.01
52-week high
$21.39
52-week low
$8.31
Average daily volume
1.5M
Financial strength
Current ratio
0.958
Quick ratio
0.854
Long term debt to equity
208.222
Total debt to equity
213.182
Interest coverage (TTM)
0.31%
Profitability
EBITDA (TTM)
98.3
Gross margin (TTM)
19.30%
Net profit margin (TTM)
-3.18%
Operating margin (TTM)
0.97%
Effective tax rate (TTM)
-9.51%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
0.58%
Return on equity (TTM)
-15.30%
Valuation
Price to revenue (TTM)
0.636
Price to book
3.31
Price to tangible book (TTM)
-1.72
Price to free cash flow (TTM)
8.678
Free cash flow yield (TTM)
11.52%
Free cash flow per share (TTM)
2.105
Growth
Revenue change (TTM)
-2.09%
Earnings per share change (TTM)
-91.94%
3-year revenue growth (CAGR)
-3.11%
3-year earnings per share growth (CAGR)
-16.04%
What the Analysts think about Fortrea Holdings
Analyst ratings (Buy, Hold, Sell) for Fortrea Holdings stock.
Fortrea Holdings Financial Performance
Revenues and expenses
Fortrea Holdings Earnings Performance
Company profitability
Fortrea Holdings News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.